Herbas VPB

Spausdinti
EN | LT
LT - MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES
EN - MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. A61P 31/12 (2018.01)
C07D 239/54 (2006.01)
C07F 7/18 (2006.01)
A61P 35/00 (2018.01)
C07D 239/54 (2013.01)
C07F 9/6512 (2006.01)
C07F 9/6512 (2013.01)
C07F 9/6561 (2006.01)
C07H 21/02 (2013.01)
C07H 21/02 (2006.01)
A61K 9/00 (2006.01)
C07F 9/65616 (2013.01)
A61K 9/1271 (2013.01)
A61K 9/08 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/127 (2006.01)
C12N 15/88 (2013.01)
A61K 31/513 (2006.01)
C12N2310/14 (2013.01)
A61K 31/713 (2006.01)
C12N 15/113 (2013.01)
A61K 48/00 (2006.01)
C12N2310/323 (2013.01)
A61P 31/12 (2006.01)
C12N2310/322 (2013.01)
A61P 35/00 (2006.01)
Y02P 20/55 (2015.11)
C12N 15/00 (2006.01)
C12N 15/88 (2006.01)
C12N 15/113 (2010.01)
Europos patentas
(11) Patento numeris 3643706
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 18817223.3
Europos patento paraiškos padavimo data 2018-06-14
(97) Europos patento paraiškos paskelbimo data 2020-04-29
(45) Paskelbimo apie Europos patento išdavimą data 2023-11-15
(46) Apibrėžties vertimo paskelbimo data
Tarptautinės paraiškos padavimo
(86) Numeris PCT/JP2018/022663
Data 2018-06-14
Tarptautinės paraiškos paskelbimo
(87) Numeris WO 2018/230624
Data 2018-12-20
Prioriteto paraiškos
(30) Numeris Data Šalis
2017118572 2017-06-16 JP
Išradėjai
(72)
TAKAHASHI Yoshinori , JP
SUZUKI Yuta , JP
Savininkas
(73) Eisai R&D Management Co., Ltd. , 4-6-10 Koishikawa Bunkyo-ku, Tokyo 112-8088, JP
Pavadinimas
(54) MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES
  MODIFIED NUCLEIC ACID MONOMERS AND OLIGONUCLEIC ACID ANALOGUES, WITH HIGH BIOLOGICAL STABILITY AND TARGET GENE SILENCING ACTIVITY, FOR USE IN THERAPY AND DIAGNOSIS OF CANCER AND VIRAL DISEASES